R&D News | pharmaphorum

News

US Congress passes bill to end Parkinson’s disease

The US Senate has joined the House of Representatives in approving the first-ever federal bill dedicated to ending Parkinson’s disease, modelled on similar legislation for

News

Update: MSD confirms $3bn takeover of EyeBio

MSD has confirmed a $3 billion takeover deal for ophthalmology biotech EyeBio and its drug candidate for diabetic macular oedema (DME) and neovascular age-related macular

News

AstraZeneca throws its hat into the oral PCSK9 ring

AstraZeneca has reported the first clinical data with its oral PCSK9 inhibitor AZD0780, which it hopes could offer an alternative to current injectable drugs used to lower

News

Trial readout sets up filings for Insmed bronchiectasis drug

Shares in Insmed have rocketed after the biotech reported positive results in a highly-anticipated clinical trial of brensocatib in the respiratory disorder bronchiectasis

News

J&J snaps up atopic dermatitis drug in $1.25bn Numab deal

Johnson & Johnson has reached an agreement to acquire a bispecific antibody for atopic dermatitis (AD) from Numab Therapeutics in an all-cash deal valued at $1.25 bill

News

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

Anglo-US biotech NodThera has named former Jazz Pharma executive Dan Swisher as its new chief executive, replacing Alan Watt, who will take on the dual roles of president

US Congress passes bill to end Parkinson’s disease

Update: MSD confirms $3bn takeover of EyeBio

AstraZeneca throws its hat into the oral PCSK9 ring

Trial readout sets up filings for Insmed bronchiectasis drug

J&J snaps up atopic dermatitis drug in $1.25bn Numab deal

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

Lift for UK healthtech as fund bags £100m from national bank

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks